Sigrid Therapeutics notes the funds will be instrumental in accelerating the commercialisation of SiPore® across diverse markets, including medical devices, food supplements, veterinary, and oral health.
October 31, 2023
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Sigrid Therapeutics notes the funds will be instrumental in accelerating the commercialisation of SiPore® across diverse markets, including medical devices, food supplements, veterinary, and oral health.